DDAH1 and metabolic dysfunction-associated steatotic liver disease: Moreover, in vivo studies have demonstrated that overexpression of DDAH1 mitigates metabolic dysfunctions, such as lipid accumulation and inflammation, in high-fat-fed mice and mice with non-alcoholic fatty liver disease (NAFLD) [34].